<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Rink M</submitter><funding>German Center for Infection Research</funding><pagination>853</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12466468</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(9)</volume><pubmed_abstract>&lt;h4>Background/objectives&lt;/h4>While antibiotic prophylaxis is crucial for preventing infections, its impact on the development of antibiotic-resistant infections and clinical outcomes remains underexplored. We aimed to systematically assess the impact of medical and surgical antibiotic prophylaxis (SAP) on the development of antibiotic-resistant infections, clinical outcomes, and costs.&lt;h4>Methods&lt;/h4>A systematic review and meta-analysis of the effect of antibiotic prophylaxis on antibiotic-resistant infections, mortality, length of hospital stay, and/or costs was conducted in hemato-oncological or surgical patient populations. Pooled estimates of the relative risk (RR) or weighted mean difference (WMD) were derived using random-effect meta-analysis.&lt;h4>Results&lt;/h4>Of 10,409 screened stud</pubmed_abstract><journal>Antibiotics (Basel, Switzerland)</journal><pubmed_title>The Impact of Antibiotic Prophylaxis on Antibiotic Resistance, Clinical Outcomes, and Costs in Adult Hemato-Oncological and Surgical Patients: A Systematic Review and Meta-Analysis.</pubmed_title><pmcid>PMC12466468</pmcid><funding_grant_id>TTU 08.707</funding_grant_id><pubmed_authors>Bitzer M</pubmed_authors><pubmed_authors>Nikolai LA</pubmed_authors><pubmed_authors>Tacconelli E</pubmed_authors><pubmed_authors>Rink M</pubmed_authors><pubmed_authors>Gopel S</pubmed_authors><pubmed_authors>Gladstone BP</pubmed_authors></additional><is_claimable>false</is_claimable><name>The Impact of Antibiotic Prophylaxis on Antibiotic Resistance, Clinical Outcomes, and Costs in Adult Hemato-Oncological and Surgical Patients: A Systematic Review and Meta-Analysis.</name><description>&lt;h4>Background/objectives&lt;/h4>While antibiotic prophylaxis is crucial for preventing infections, its impact on the development of antibiotic-resistant infections and clinical outcomes remains underexplored. We aimed to systematically assess the impact of medical and surgical antibiotic prophylaxis (SAP) on the development of antibiotic-resistant infections, clinical outcomes, and costs.&lt;h4>Methods&lt;/h4>A systematic review and meta-analysis of the effect of antibiotic prophylaxis on antibiotic-resistant infections, mortality, length of hospital stay, and/or costs was conducted in hemato-oncological or surgical patient populations. Pooled estimates of the relative risk (RR) or weighted mean difference (WMD) were derived using random-effect meta-analysis.&lt;h4>Results&lt;/h4>Of 10,409 screened stud</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Aug</publication><modification>2026-05-02T03:16:24.664Z</modification><creation>2026-05-02T03:09:33.211Z</creation></dates><accession>S-EPMC12466468</accession><cross_references><pubmed>41009832</pubmed><doi>10.3390/antibiotics14090853</doi></cross_references></HashMap>